PhaseV vs Queen Mary University of London Spinouts
PhaseV vs Queen Mary University of London Spinouts, compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: PhaseV is on 56/100 and Queen Mary University of London Spinouts on 7/100.
Where each one leads
PhaseV
- our overall score: 56/100 against 7/100
- agent readiness: 42/100 against 25/100
Queen Mary University of London Spinouts
- domain rating: 84/100 against 33/100
At a glance
| Measure | PhaseV | Queen Mary University of London Spinouts |
|---|---|---|
| What it is | Develops a platform for adaptive clinical trial design and closed-loop execution. | A collective of grant-stage to Series A companies spun out from Queen Mary University of London, actively seeking investment in sectors like life sciences, AI, and sustainability. |
| Category | Life Sciences, Clinical Trials, Optimization, HealthTech | Life Sciences, Sustainability, University Spinout, Technology Transfer |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Platform |
| Founded | 2023 | Not published |
| Headquarters | Tel Aviv, Israel | London, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | PhaseV | Queen Mary University of London Spinouts |
|---|---|---|
| Employees | 61 | Not published |
| Headcount growthLast 12 months | +173.2% | Not published |
| Total funding | $65.0M | Not published |
| Latest round | Series A | Funding Round |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 6,602 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | PhaseV | Queen Mary University of London Spinouts |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 7/100 |
| Traction | 57/100 | Not published |
| Team | 70/100 | Not published |
| Search visibility | 40/100 | Not published |
| Quality | 55/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | F (25/100) |
| Domain ratingLink authority, 0-100 | 33/100 | 84/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | PhaseV | Queen Mary University of London Spinouts |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | CloudFront |
| CMS | Webflow | Not detected |
| Frameworks | Not detected | Jquery, Tailwind CSS |
| Analytics | Google Analytics 4 | Google Tag Manager, Linkedin Insight |
PhaseV vs Queen Mary University of London Spinouts: common questions
Which is better, PhaseV or Queen Mary University of London Spinouts?
On our 0-100 score PhaseV rates higher (56/100 against 7/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.
How do PhaseV and Queen Mary University of London Spinouts compare on the numbers?
PhaseV leads on our overall score (56/100 against 7/100), agent readiness (42/100 against 25/100). Queen Mary University of London Spinouts leads on domain rating (84/100 against 33/100).
Read the full PhaseV review and pricing or the Queen Mary University of London Spinouts review and pricing. You can also browse other PhaseV alternatives we track.